OMEGATRAC, MODEL Z105

K013307 · Teftec Corp. · ITI · Feb 8, 2002 · Physical Medicine

Device Facts

Record IDK013307
Device NameOMEGATRAC, MODEL Z105
ApplicantTeftec Corp.
Product CodeITI · Physical Medicine
Decision DateFeb 8, 2002
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 890.3860
Device ClassClass 2
AttributesTherapeutic

Indications for Use

IntegaTract design definitions and functional parameters are indicated for usage for anyone with limited mobility due to weak, amputated or non-functional extremities or improper, unsafe or non-existent gait patterns. Also, due to the specific driving control supplied by the transaxle, persons with spasticity or ataxic movements in their extremity's that are not candidates for other types of mobility without extensive modification may be appropriate for the SmegaTrac® with no modifications. This usage would be indicated but not limited to the following types of injury's: Spinal Cord Injury (SCI) Head Injury (CHI) Muscular Dystrophy (MD) Cerebral Palsy (CP) Brown Sequard's Syndrome Severe Arthritics (RA) (OA) Multiple Sclerosis Huntington's Corea Traumatic Brain Injury (TBI) Amyotrophic Lateral Sclerosis (ALS) Anoxic Encephalopathy Anoxia Guillain-Barre Syndrome Quadriplegia Paraplegia Triplegia Hemiplegia Tetraplegia Proximal Extremity Weakness Cerebral Vascular Accident (CVA or Stroke) Quadriparesis Obesity Parkinson's This is not meant to be an all-inclusive list, anyone needing power assistance with their mobility may be an appropriate client for an QmegaTrac® powered wheelchair. This would usually be decided by clinical evaluation of the client's strength, sitting balance, mobility needs, size constraints and driving capability at their local rehab facility.

Device Story

Model Z105 ΩmegaTrac® is a powered wheelchair designed to provide mobility assistance to individuals with limited extremity function or gait instability. Device utilizes a specialized transaxle driving control system to accommodate users with spasticity or ataxic movements without requiring extensive modifications. Operated by the patient, the wheelchair provides motorized propulsion based on user input via control interface. Used in clinical, home, or community settings; selection and configuration are typically determined by clinical evaluation of patient strength, balance, and mobility needs at a rehabilitation facility. Device enhances patient independence by providing reliable power-assisted mobility.

Clinical Evidence

No clinical data provided. Substantial equivalence is based on device design and intended use.

Technological Characteristics

Powered wheelchair featuring a specialized transaxle for driving control. Designed for users with limited mobility, including those with spasticity or ataxia. Operates via electric motor propulsion. No specific materials, software, or connectivity standards are detailed in the provided documentation.

Indications for Use

Indicated for individuals with limited mobility due to weak, amputated, or non-functional extremities, or unsafe/non-existent gait patterns. Appropriate for patients with spasticity or ataxic movements. Applicable to conditions including SCI, TBI, MD, CP, MS, ALS, CVA, and others causing mobility impairment. Intended for use by individuals requiring power assistance for mobility, determined via clinical evaluation.

Regulatory Classification

Identification

A powered wheelchair is a battery-operated device with wheels that is intended for medical purposes to provide mobility to persons restricted to a sitting position.

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of an eagle with three curved lines representing its wings. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 FEB 0 8 2002 Mr. Thomas E. Finch III Vice President Teftec Corporation 12450 Network Boulevard San Antonio, Texas 78249 Re: K013307 Trade/Device Name: Model Z105 Ωmega Trac® Powered Wheelchair Regulation Number: 890.3860 Regulation Name: Powered wheelchair Regulatory Class: II Product Code: ITI Dated: December 20, 2001 Received: December 26, 2001 Dear Mr. Finch: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments. or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can has found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ ## Page 2 - Mr. Thomas E. Finch III This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, R. Mark A. Millen Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ ## 510 (k) number (if known): KO) 330 + DEVICE NAME: Model Z105 ΩmegaTrac® Powered Wheelchair INDICATIONS FOR USE: Indications for use for the Model Z105 ΩmegaTrac® Powered Wheelchair base: IntegaTract design definitions and functional parameters are indicated for usage for anyone with limited mobility due to weak, amputated or non-functional extremities or improper, unsafe or non-existent gait patterns. Also, due to the specific driving control supplied by the transaxle, persons with spasticity or ataxic movements in their extremity's that are not candidates for other types of mobility without extensive modification may be appropriate for the SmegaTrac® with no modifications. This usage would be indicated but not limited to the following types of injury's: Spinal Cord Injury (SCI) Head Injury (CHI) Muscular Dystrophy (MD) Cerebral Palsy (CP) Brown Sequard's Syndrome Severe Arthritics (RA) (OA) Multiple Sclerosis Huntington's Corea Traumatic Brain Injury (TBI) Amyotrophic Lateral Sclerosis (ALS) Anoxic Encephalopathy Anoxia Guillain-Barre Syndrome Quadriplegia Paraplegia Triplegia Hemiplegia Tetraplegia Proximal Extremity Weakness Cerebral Vascular Accident (CVA or Stroke) Quadriparesis Obesity Parkinson's This is not meant to be an all-inclusive list, anyone needing power assistance with their mobility may be an appropriate client for an QmegaTrac® powered wheelchair. This would usually be decided by clinical evaluation of the client's strength, sitting balance, mobility needs, size constraints and driving capability at their local rehab facility. If you have any further questions, please feel free to contact us directly. (Please Do Not Write Below This Line-Continue On Another Page If Needed.) Concurrence of CDRH/Office of Device Evaluation (ODE) (Division Sign-Off) Division of General, Restorative and Neurological Devices Prescription Use ***_*** OR Over-The-Counter-Use **_** (Per 21 CFR 801.109) 510(k) Number K 013307 (Optional Format 1 - 2 - 96) Revised 11/13/1998
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...